DIRECTOR DEALINGS: ValiRx Directors Buy 5.3 Million Shares

Tue, 24th Jun 2014 09:23

LONDON (Alliance News) - ValiRx PLC Tuesday said a group of directors including Chief Executive Officer Satu Vainikka bought a combined total of approximately 5.3 million shares shares at a price of 0.31 pence per share Monday.

Details are as follows.

Director	Number of shares acquired	Total number of shares held subsequent to the acquisition
Satu Vainikka	789,516	23,113,714
Gerry Desler	1,595,968	12,733,921
Seppo Makinen	1,273,387	1,273,387
Kevin Alexander	1,612,903	8,034,843

Shares in the bio-therapeutic company were down 1.7% at 0.295p Tuesday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

Related Shares

More News

21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeu...

19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following lega...

12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug ...